Navigation Links
Small-Cell Lung Cancer Drug Market Will More Than Double to Over $684 Million in 2017
Date:4/8/2009

Although Market Growth Will be Robust, Drug Development Has Been Disappointing in Recent Years, According to a New Report from Decision Resources

WALTHAM, Mass., April 8 /PRNewswire/ -- Decision Resources, one of the world's leading research and advisory firms for pharmaceutical and healthcare issues, finds that the small-cell lung cancer drug market will more than double from just under $250 million in 2007 to more than $684 million in 2017, owing to the launches of Genentech/Roche/Chugai's Avastin and Celgene's amrubicin (currently marketed in Japan as Calsed by Nippon Kayaku) to treat the indication.

The new Pharmacor report entitled Small-Cell Lung Cancer finds that the launches, beginning in 2012, of Avastin as a first-line add-on to standard chemotherapy and amrubicin as a second-line therapy will drive robust 22 percent annual growth from 2012 to 2017 in the United States, France, Germany, Italy, Spain, the United Kingdom and Japan.

Although market growth will be robust from 2012 to 2017, drug development in recent years in small-cell lung cancer has, overall, been very disappointing. Recent clinical trials have largely eliminated Pfizer's Camptosar/Campto (Daiichi Sankyo's Topotecin), Eli Lilly's Alimta, and GlaxoSmithKline/Nippon Kayaku's Hycamtin from potential first-line status in the indication. Furthermore, despite the impressive sales that Avastin and amrubicin will add to the market, these therapies will have only niche roles in small-cell lung cancer treatment.

"Avastin and amrubicin will each garner only a limited share of the total small-cell lung cancer patient population," said Decision Resources Analyst Janie Mackay, Ph.D. "However, their high price points in an increasingly generic market, mean that those patient shares will translate into substantial market shares."

Despite the disappointing drug development environment, the recent designation
'/>"/>

SOURCE Decision Resources
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine news :

1. Conventional prognostic factors fail to explain better prostate cancer survival in most Asian men
2. Survival differences by race most apparent in advanced stages of breast cancer
3. MRI finds breast cancer before it becomes dangerous
4. Investigators uncover intriguing clues to why persistent acid reflux sometimes turns into cancer
5. Pathway links inflammation, angiogenesis and breast cancer
6. Radiologists encouraged to look beyond cancer for clinically unseen diseases
7. Diet high in meat, fat and refined grains linked to risk for colon cancer recurrence, death
8. Immune deficiency linked to a type of eye cancer
9. Drop in breast cancer incidence linked to hormone use, not mammograms
10. Breast cancer prevention practices vary across Canada
11. First biomarker discovered that predicts prostate cancer outcome
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/21/2014)... PA (PRWEB) September 21, 2014 "I ... their legs and back but haven’t the money for ... I’d like to have such a product for myself." ... effective way to stretch the thigh muscles and align ... as well as relieves discomfort of pinched nerves. Compact ...
(Date:9/21/2014)... Best Cheap Hosting USA, one of ... Bluehost and GreenGeeks are the best Reseller hosting suppliers ... reseller hosting supplier. Actually, these companies have outperformed their ... support. People can get the best web hosting at ... According to the manager, reseller hosting is a very ...
(Date:9/21/2014)... (PRWEB) September 21, 2014 To accommodate ... e-powered platform and provide more trendy items. Recently, the ... . By offering the new and elegant wedding gowns, ... get what they need in an easy way. Its ... deeply discounted rates, from 12% off to 62% off. ...
(Date:9/21/2014)... 21, 2014 “Cluster headaches are sometimes ... and difficult to resolve,” said Steve Young of Ew ... of a pain that is more intense.” , “It ... cluster headaches, or migraines, that medical research is pointing ... system,” he added. , Serotonin (5-HT, 5-hydroxytryptamine) is a ...
(Date:9/21/2014)... C8 lawsuits move forward in the ... list of 20 possible C8 lawsuits selected for ... reports Wright & Schulte LLC. Court records show these ... C8 lawsuits filed that represent individuals who purportedly developed ... result of being exposed to water contaminated by the ...
Breaking Medicine News(10 mins):Health News:Best Cheap Hosting USA Announces The Best Reseller Hosting Suppliers In 2014 2Health News:Angeldress.co.uk Launches New Range Of 2014 Vintage Wedding Dresses In Its Online Store 2Health News:Homeostasis: Equinox Serotonin (5HT) Headache Stories ~ New on the Bryan William Brickner Blog 2Health News:C8 Lawsuit Claims Move Forward as Six Possible Cases for Bellwether Trials Selected in DuPont Water Contamination Lawsuits, Reports Wright & Schulte LLC 2Health News:C8 Lawsuit Claims Move Forward as Six Possible Cases for Bellwether Trials Selected in DuPont Water Contamination Lawsuits, Reports Wright & Schulte LLC 3Health News:C8 Lawsuit Claims Move Forward as Six Possible Cases for Bellwether Trials Selected in DuPont Water Contamination Lawsuits, Reports Wright & Schulte LLC 4
... Washington Teenage girls are setting new trends in drug ... , a report has shown. ,Teen boys have ... Wanting a slice of the vice, teen girls have become ... drugs, according to the White House Office of National Drug ...
... finds that sleep deprivation can adversely affect a persons ... of gains and making light of ones losses ... neural underpinnings of risky decision making under conditions of ... studied healthy volunteers as they underwent functional magnetic resonance ...
... not get training posts through the flawed Medical Training ... government is stalling on a new contract for ... figures show that 34,250 doctors are chasing 18,500 specialist ... far given no commitment that trainee doctors will be ...
... definite link between pregnancy, migraine and stroke, US researchers ... one. ,In fact, Cheryl Bushnell, assistant professor ... Disease in Durham, explained that pregnant women who suffered ... than pregnant women who did not suffer migraine. ...
... Science & Technology, Government of India and the ... today to address a major obstacle in AIDS ... elicit neutralizing antibodies against HIV. A new Indian ... and the Department of Biotechnology, will comprise top ...
... disturbing link between Reclast, made by Novartis AG and Fosamax manufactured ... in a small number of women users. Both are known bone-building ... more pronounced with Reclast, given as an annual shot. But there ... took the leading osteoporosis pill, Fosamax by Merck & Co. They ...
Cached Medicine News:Health News:Sleep Deprivation can Affect Competent Decision-making 2Health News:Junior Doctors Facing More Misery Because of Contract Deadlock: BMA 2Health News:DBT And IAVI Forge Partnership To Develop Next Generation Vaccine Candidates 2Health News:DBT And IAVI Forge Partnership To Develop Next Generation Vaccine Candidates 3Health News:Anti-osteoporosis Drugs Could Result in Irregular Heart Rhythm, New Study 2
(Date:9/19/2014)... Sept. 19, 2014 The Parenteral Drug Association ... global post-approval changes protocols. The new ... topic expressed by industry participants and regulatory authority representatives ... month in Washington, DC . Representatives ... hand for the workshop. Attendees indicated openness to engaging ...
(Date:9/19/2014)... 2014 Today, iHealth Lab Inc. announced it has ... for its first institutional round of funding. The strategic ... reach, accelerate growth and innovation, and invest in additional ... Xiaomi Ventures will join iHealth,s board of directors, bringing ... ecommerce. "We are very pleased to have ...
(Date:9/19/2014)... , September 19, 2014 ... ) has announced the addition of the ... report to their offering.      ... have been broadly classified into wide categories ... used for the treatment of different gynecological ...
Breaking Medicine Technology:PDA Launches Effort to Harmonize Global Post-Approval Changes Protocols 2iHealth Raises $25 Million to Fuel Growth and Global Market Share 2Global Gynecological Devices Market 2014-2018: Key Vendors are Bayer, Boston Scientific, CooperSurgical, Ethicon, Hologic, Medtronic, Olympus and Stryker 2Global Gynecological Devices Market 2014-2018: Key Vendors are Bayer, Boston Scientific, CooperSurgical, Ethicon, Hologic, Medtronic, Olympus and Stryker 3
... in ... developing countries, SEATTLE, Jan. 22 ... has joined the Global Health,Program as director of Global Health Delivery. ... medical and public health,efforts, including preparations for a potential influenza pandemic., ...
... Diagnostic Application of Research Technologies, FULLERTON, Calif., ... ) announced today that it has signed four ... to direct assay,research and acquire licenses for intellectual ... for the company,s future molecular,diagnostic instrument. Under the ...
Cached Medicine Technology:Dr. Rajeev Venkayya Joins Gates Foundation as Director of Global Health Delivery 2Beckman Coulter Announces Licensing Agreements for Molecular Tests with National University of Ireland, Galway 2Beckman Coulter Announces Licensing Agreements for Molecular Tests with National University of Ireland, Galway 3
Alexander periosteal elevators....
Lambotte periosteal elevators....
Cottle periosteal & skin elevator, 7 1/2", slightly curved blade, 9 mm wide....
Dolwick-Reich Condyle periosteal elevator, 17.5 cm, 7"....
Medicine Products: